No treatments currently exist for the common condition that causes progressive vision loss "Our findings suggest that vitronectin, which is shaped like a sticky propeller, orchestrates the formation ...
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback